▁Chron 10.375
ic 5.49609375
▁pain 11.6953125
▁is 5.5546875
▁still 6.25390625
▁considered 5.03125
▁to 1.7314453125
▁be 0.4521484375
▁an 3.0078125
▁extreme 5.94921875
▁issue 7.3828125
▁among 7.328125
▁at 6.82421875
▁least 1.4091796875
▁ 2.65234375
8 3.197265625
% 4.31640625
▁of 1.8486328125
▁the 1.236328125
▁residents 6.89453125
▁of 2.294921875
▁progress 9.4140625
ive 0.9912109375
▁countries 6.890625
. 2.107421875
▁The 2.505859375
▁introduction 7.234375
▁of 0.257568359375
▁the 1.609375
▁study 6.78515625
▁describes 8.03125
▁the 0.865234375
▁apparent 9.0703125
▁link 6.33203125
▁between 0.5322265625
▁pain 6.2734375
▁and 0.7470703125
▁dem 8.3671875
oral 3.49609375
ization 0.281982421875
. 1.4599609375
▁Chron 6.23046875
ic 0.0287628173828125
▁pain 0.312255859375
▁is 1.30078125
▁always 6.3828125
▁accompanied 2.1875
▁by 0.05865478515625
▁negative 4.90234375
▁emot 1.482421875
ional 1.314453125
▁experiences 2.96875
▁and 2.12109375
▁blocks 11.046875
▁a 4.15234375
▁person 1.4033203125
’ 24.859375
s 1.9921875
▁ability 1.8544921875
▁to 0.047698974609375
▁receive 6.296875
▁joy 4.91796875
▁and 1.3935546875
▁satisfaction 3.03125
▁from 1.216796875
▁life 1.033203125
. 0.3251953125
▁The 1.890625
▁research 3.916015625
▁investig 5.296875
ates 0.46044921875
▁the 0.483154296875
▁development 5.9140625
▁of 0.1756591796875
▁de 3.84375
pression 0.254638671875
▁and 1.2861328125
▁anx 2.255859375
iety 0.004974365234375
▁among 2.369140625
▁patients 2.458984375
▁receiving 4.5
▁ph 6.625
arma 1.783203125
ce 0.00861358642578125
ut 0.00045871734619140625
ical 0.0106964111328125
▁op 5.04296875
io 0.1884765625
ids 0.6259765625
▁and 2.384765625
▁medical 6.171875
▁mar 1.498046875
iju 0.048919677734375
ana 0.00020039081573486328
▁( 4.390625
MM 0.68310546875
) 3.458984375
▁as 2.83984375
▁severe 9.921875
▁pain 1.6123046875
kill 3.076171875
ers 0.0019130706787109375
. 0.52880859375
▁It 3.236328125
▁comp 5.125
ares 0.052032470703125
▁the 0.630859375
▁effic 6.4140625
acy 0.00827789306640625
▁of 0.277099609375
▁pres 5.10546875
cri 1.7626953125
ptions 0.6845703125
▁and 2.298828125
▁exam 5.8203125
ines 0.01125335693359375
▁the 0.4482421875
▁possibility 3.796875
of 10.890625
▁post 7.35546875
- 0.8984375
tre 2.494140625
at 0.028076171875
ment 0.0118560791015625
▁de 2.08203125
pression 0.11181640625
. 1.873046875
<0x0A> 2.53515625
There 4.83984375
▁is 1.03125
▁currently 4.52734375
▁a 1.1650390625
▁severe 4.98828125
▁lack 3.287109375
▁of 0.0304412841796875
▁information 2.095703125
▁about 1.435546875
▁the 0.482666015625
▁effects 2.916015625
▁of 0.07464599609375
▁op 1.861328125
i 3.966796875
ates 0.1552734375
. 3.802734375
▁They 4.95703125
▁manage 8.9140625
▁pain 3.423828125
▁successfully 5.765625
, 1.0634765625
▁but 0.336669921875
▁the 2.681640625
▁past 9.453125
▁few 2.568359375
▁dec 0.787109375
ades 0.00014197826385498047
▁indicated 9.421875
▁the 2.107421875
▁growing 4.609375
▁concern 3.525390625
▁regarding 2.87109375
▁op 3.583984375
iate 0.69775390625
▁ab 1.51953125
use 0.0089874267578125
▁in 3.44140625
▁forms 10.484375
▁of 0.41015625
▁over 3.314453125
d 0.3681640625
ose 0.1893310546875
▁and 0.7158203125
▁add 1.1044921875
iction 0.028900146484375
. 0.21337890625
▁A 3.998046875
▁more 5.65625
▁manage 8.9453125
able 0.005462646484375
▁and 2.240234375
▁sa 2.2734375
fer 0.00012040138244628906
▁alternative 1.6708984375
▁might 6.30859375
▁be 0.179443359375
▁medical 2.6484375
▁mar 0.1864013671875
iju 0.00495147705078125
ana 0.0008878707885742188
. 1.521484375
▁However 2.9609375
, 0.01019287109375
▁the 1.619140625
▁legal 4.234375
▁status 1.130859375
▁and 2.828125
▁novel 9.2578125
ty 0.73779296875
▁of 0.2044677734375
▁this 1.6357421875
▁drug 2.056640625
▁do 5.05078125
▁not 0.07623291015625
▁allow 1.0283203125
▁finding 8.859375
▁a 2.3046875
▁large 4.31640625
▁number 1.41796875
▁of 0.006969451904296875
▁studies 1.33984375
▁on 1.564453125
▁its 0.966796875
▁effect 2.0625
iveness 0.387939453125
. 0.97216796875
▁Specifically 8.28125
, 0.12646484375
▁it 2.744140625
▁concerns 4.79296875
▁the 0.63671875
▁emot 7.41015625
ional 0.0190277099609375
▁condition 5.3984375
▁of 0.386962890625
▁patients 0.7080078125
▁experien 6.375
cing 8.845329284667969e-05
▁chron 1.1787109375
ic 0.0026264190673828125
▁pain 0.099609375
. 0.6826171875
▁This 3.12890625
▁research 2.982421875
▁paper 6.453125
▁a 2.185546875
ims 0.0004901885986328125
▁to 0.11126708984375
▁analyze 3.0859375
▁levels 9.5390625
▁of 0.03369140625
▁de 0.56982421875
pression 0.037841796875
▁and 0.272216796875
▁anx 0.04449462890625
iety 0.001434326171875
▁among 0.81201171875
▁people 3.314453125
▁receiving 0.892578125
▁ther 7.90234375
apy 0.3642578125
▁by 5.23828125
▁comparing 8.1015625
▁the 0.96875
▁effects 2.185546875
▁of 0.0296173095703125
▁ph 2.5078125
arma 0.043792724609375
ce 0.001247406005859375
ut 0.00011348724365234375
ical 0.004047393798828125
▁op 0.284423828125
io 0.169677734375
ids 0.05963134765625
▁and 0.280517578125
▁MM 1.4189453125
. 1.0712890625
<0x0A> 1.0771484375
The 1.3564453125
▁study 2.029296875
▁was 2.0390625
▁conducted 0.7490234375
▁in 1.5205078125
▁the 1.4208984375
▁form 2.216796875
▁of 0.00921630859375
▁collection 9.9609375
▁and 1.751953125
▁analysis 0.69091796875
▁of 0.0457763671875
▁statistical 4.1796875
▁data 0.123046875
. 0.923828125
▁Part 4.95703125
icip 0.07208251953125
ants 0.04827880859375
▁were 0.73974609375
▁rec 3.279296875
ru 0.0011692047119140625
ited 7.271766662597656e-05
▁for 4.02734375
▁six 7.56640625
▁months 0.52099609375
▁at 3.75
▁two 2.515625
▁major 5.50390625
▁pain 3.126953125
▁relief 5.2890625
▁cent 1.5380859375
ers 0.089111328125
▁in 0.71435546875
▁Israel 4.359375
. 0.443115234375
▁The 1.19140625
▁research 2.19140625
ers 1.546875
▁used 2.720703125
▁The 7.83203125
▁De 4.203125
pression 0.01357269287109375
▁Module 10.0546875
▁of 0.9599609375
▁the 0.3408203125
▁Pat 2.29296875
ient 0.00788116455078125
▁Health 0.08709716796875
▁Question 0.01473236083984375
naire 0.0203399658203125
▁and 3.390625
▁the 0.74658203125
▁General 1.7041015625
ized 0.68359375
▁An 0.0163116455078125
x 0.00015461444854736328
iety 0.002834320068359375
▁Dis 0.52099609375
order 0.0355224609375
▁Sc 1.20703125
ale 0.0693359375
▁to 1.7763671875
▁interview 7.09375
▁participants 2.03125
, 3.5859375
▁evaluate 5.65625
▁their 0.74755859375
▁answers 6.51171875
, 0.919921875
▁and 0.1534423828125
▁conduct 4.484375
▁the 2.28515625
▁study 2.26953125
. 0.224609375
▁To 5.12109375
▁specifically 9.9140625
▁evaluate 2.541015625
▁and 4.37890625
▁compare 0.95654296875
▁the 0.330810546875
▁prob 11.1328125
abilities 0.1722412109375
▁of 0.1302490234375
▁de 0.81396484375
pression 0.037353515625
▁or 4.61328125
▁anx 0.03662109375
iety 0.00037384033203125
▁among 1.69140625
▁the 2.2734375
▁diverse 8.9140625
▁groups 1.5703125
, 1.447265625
▁the 1.0234375
▁study 2.6796875
▁used 1.634765625
▁multiple 4.7109375
▁log 2.859375
istic 0.0361328125
▁regression 0.103271484375
▁analysis 0.64794921875
▁and 2.580078125
▁chose 8.875
▁medical 7.43359375
▁mar 0.329345703125
iju 0.0020046234130859375
ana 0.0002856254577636719
▁as 0.79150390625
▁the 1.09765625
▁control 2.759765625
▁group 0.54931640625
. 0.295166015625
<0x0A> 0.748046875
This 3.46484375
▁type 6.09765625
▁of 0.007137298583984375
▁study 1.67578125
▁is 1.279296875
▁the 3.4140625
▁most 1.8818359375
▁reve 9.1640625
aling 0.0007848739624023438
▁and 1.0791015625
▁inclus 6.51953125
ive 0.0026416778564453125
, 2.27734375
▁as 1.9140625
▁it 0.35107421875
▁contains 4.921875
▁direct 6.3125
▁responses 5.0
▁from 0.814453125
▁a 3.869140625
▁large 0.9228515625
▁number 0.4345703125
▁of 0.00347137451171875
▁participants 1.44921875
. 0.6669921875
▁All 4.65234375
▁tools 9.1640625
▁in 4.52734375
▁the 0.68896484375
▁form 3.53125
▁of 0.0386962890625
▁question 1.732421875
na 0.035400390625
ires 0.00011658668518066406
▁and 2.16015625
▁scales 3.068359375
▁have 3.6953125
▁already 4.44921875
▁been 0.1728515625
▁used 1.9404296875
▁and 2.158203125
▁proved 4.21484375
▁their 1.8193359375
▁effic 3.90625
acy 0.00010383129119873047
▁for 3.6171875
▁collect 4.59375
ing 0.0160980224609375
▁analyt 8.265625
ical 0.2393798828125
▁data 0.276611328125
. 0.433349609375
▁It 3.537109375
▁helps 4.76953125
▁to 0.92724609375
▁system 7.33984375
at 1.337890625
ize 0.00768280029296875
▁and 1.62109375
▁class 4.0390625
ify 0.002410888671875
▁distinct 9.203125
▁kinds 6.26171875
▁of 0.021881103515625
▁information 3.435546875
▁for 3.916015625
▁subsequent 4.09375
▁un 8.0234375
comp 5.40625
licated 0.05859375
▁services 11.7578125
. 0.662109375
▁Thus 4.40234375
, 0.0248870849609375
▁research 4.5078125
ers 0.53955078125
▁can 1.3720703125
▁compare 3.9765625
▁the 0.95068359375
▁effects 3.0078125
▁of 0.10345458984375
▁medic 4.4453125
ations 0.88232421875
▁on 1.830078125
▁patients 2.087890625
▁of 4.5859375
▁diverse 4.03125
▁age 2.724609375
▁groups 0.67626953125
, 0.92041015625
▁background 5.0234375
s 0.2130126953125
, 0.07550048828125
▁physical 5.33984375
▁conditions 1.4189453125
, 0.09210205078125
▁emot 5.5234375
ional 0.06268310546875
▁states 1.3798828125
, 0.11016845703125
▁and 0.444091796875
▁so 3.205078125
▁on 0.318603515625
. 0.09332275390625
<0x0A> 0.65234375
The 1.0908203125
▁analysis 4.5546875
▁of 0.55322265625
▁any 8.8359375
▁human 6.09765625
▁reaction 4.8515625
▁has 4.53125
▁a 1.7509765625
▁high 4.47265625
▁potential 3.423828125
▁of 1.6201171875
▁subject 6.15625
iveness 3.857421875
▁and 1.3857421875
▁bias 2.271484375
, 1.8681640625
▁especially 2.423828125
▁regarding 4.375
▁people 4.48828125
▁in 3.94140625
▁severe 4.296875
▁pain 0.3056640625
▁and 2.662109375
▁un 5.33984375
stable 1.828125
▁emot 0.83935546875
ional 0.1676025390625
▁condition 2.564453125
. 0.0750732421875
▁Perhaps 8.921875
▁some 5.0625
▁patients 2.34375
▁tend 5.44921875
▁to 0.023345947265625
▁ex 2.583984375
agger 0.0014734268188476562
ate 0.005962371826171875
▁their 0.7548828125
▁de 5.140625
press 1.376953125
ive 0.254638671875
▁state 3.08984375
▁or 1.8916015625
▁vice 7.40234375
▁vers 0.016876220703125
a 7.605552673339844e-05
, 0.99462890625
▁de 7.453125
- 4.8828125
emph 0.953125
as 0.00560760498046875
ize 0.11761474609375
▁serious 6.6015625
▁difficulties 5.91796875
. 0.880859375
▁Because 6.1875
▁the 2.30078125
▁survey 6.1484375
▁responses 6.6875
▁were 1.58203125
▁thoroughly 7.8671875
▁anonymous 5.29296875
, 0.444091796875
▁the 1.458984375
▁research 1.5478515625
ers 0.2802734375
▁were 1.4384765625
▁unable 2.41796875
▁to 0.005413055419921875
▁carefully 8.765625
▁analyze 1.578125
▁each 3.91796875
▁patient 2.546875
’ 26.8125
s 0.7509765625
▁reaction 3.6796875
▁and 2.412109375
▁compare 3.51171875
▁it 0.90869140625
▁to 1.259765625
▁the 0.76513671875
▁actual 5.75390625
▁states 7.26953125
▁of 0.6923828125
▁condition 7.30859375
. 0.37939453125
▁More 6.8671875
▁accurate 3.810546875
▁answers 4.63671875
▁could 2.478515625
▁be 0.8984375
▁obtained 1.001953125
▁by 1.3671875
▁professional 7.4453125
▁psych 2.15625
olog 0.3212890625
ists 0.0011844635009765625
▁via 7.9296875
▁personal 3.95703125
▁communication 4.6875
▁and 1.8681640625
▁behavior 7.16015625
al 0.323486328125
▁analysis 2.2578125
. 0.22607421875
▁However 2.744140625
, 0.002803802490234375
▁this 1.9423828125
▁method 2.828125
▁of 2.28125
▁research 2.130859375
▁is 0.94482421875
▁way 7.83984375
▁more 1.7333984375
▁resource 6.53125
- 0.42138671875
int 0.5458984375
ensive 0.008575439453125
▁and 0.63916015625
▁energy 8.6875
- 0.1151123046875
consum 0.31103515625
ing 0.0018606185913085938
. 0.5966796875
<0x0A> 0.6337890625
Part 5.515625
icip 0.0870361328125
ants 0.11566162109375
▁were 1.0224609375
▁rec 1.5302734375
ru 0.0011167526245117188
ited 0.00010001659393310547
▁for 1.134765625
▁six 1.1728515625
▁months 0.020904541015625
▁at 0.465576171875
▁two 0.114013671875
▁major 0.3828125
▁pain 0.03619384765625
▁relief 0.027587890625
▁cent 0.03326416015625
ers 0.00550079345703125
▁in 0.0653076171875
▁Israel 0.0343017578125
. 0.151611328125
▁All 3.46875
▁patients 1.5498046875
▁experienced 5.54296875
▁chron 1.9228515625
ic 0.002384185791015625
▁pain 0.09588623046875
▁for 3.4921875
▁at 0.73583984375
▁least 0.0009889602661132812
▁ 1.09765625
3 1.447265625
▁months 0.228271484375
. 1.0283203125
▁The 1.4658203125
▁study 1.943359375
▁included 2.130859375
▁ 1.1181640625
8 2.873046875
9 2.771484375
0 3.576171875
▁participants 1.5166015625
, 1.23046875
▁of 1.7548828125
▁which 0.410400390625
▁ 0.14501953125
4 1.62109375
7 2.46484375
4 2.755859375
▁( 2.171875
5 0.09027099609375
9 11.234375
%) 1.029296875
▁were 0.46630859375
▁treated 4.68359375
▁sole 6.8828125
ly 0.00010991096496582031
▁with 0.46142578125
▁op 0.798828125
io 0.39404296875
ids 0.1944580078125
, 1.14453125
▁ 0.5791015625
3 1.0693359375
2 2.087890625
9 2.544921875
▁( 0.0438232421875
4 1.1796875
1 1.2587890625
%) 0.1358642578125
▁were 1.3095703125
▁treated 0.52685546875
▁with 0.1776123046875
▁MM 0.78076171875
, 0.26220703125
▁and 0.1583251953125
▁ 0.1373291015625
7 3.208984375
7 2.412109375
▁( 0.1708984375
8 3.81640625
. 1.1396484375
6 3.072265625
%) 0.054931640625
▁acquired 9.6796875
▁both 1.1669921875
▁( 7.0
Fe 10.1796875
ing 2.70703125
old 0.0194091796875
▁et 1.3955078125
▁al 0.01806640625
., 0.299072265625
▁ 0.01016998291015625
2 0.1497802734375
0 0.0003044605255126953
1 0.38525390625
7 2.046875
). 0.1265869140625
▁The 1.333984375
▁remaining 6.9609375
▁ten 8.0859375
▁participants 1.3857421875
▁who 5.60546875
▁did 1.48046875
▁not 0.007022857666015625
▁receive 1.8369140625
▁ph 3.083984375
arma 0.060150146484375
ce 0.0014238357543945312
ut 2.1457672119140625e-05
ical 0.00334930419921875
▁op 1.0126953125
io 0.07757568359375
ids 0.0228271484375
▁and 1.6591796875
▁medical 2.2890625
▁mar 0.042510986328125
iju 0.004726409912109375
ana 8.475780487060547e-05
▁were 1.2646484375
▁with 6.0390625
dra 0.138671875
wn 0.00011742115020751953
▁from 0.253662109375
▁the 0.1085205078125
▁analysis 4.6484375
▁in 4.8125
▁the 1.1826171875
▁research 4.2734375
. 0.74365234375
▁Therefore 4.83203125
, 0.00809478759765625
▁it 3.775390625
▁is 0.90576171875
▁not 2.716796875
▁possible 0.6552734375
▁to 0.021453857421875
▁compreh 6.51171875
ens 0.048736572265625
ively 0.0096282958984375
▁compare 1.91015625
▁patients 4.796875
▁taking 4.28125
▁medic 3.8671875
ations 0.473876953125
▁with 0.9609375
▁those 1.1796875
▁who 1.1171875
▁do 1.7216796875
▁not 0.00830841064453125
. 0.77978515625
<0x0A> 0.6474609375
The 1.10546875
▁study 1.67578125
▁conducted 4.73828125
▁a 2.1015625
▁correlation 5.96484375
▁type 7.390625
▁of 0.458251953125
▁research 1.9892578125
▁with 2.83984375
▁variable 7.9921875
▁measures 4.53515625
. 1.2587890625
▁It 2.130859375
▁evaluated 4.38671875
▁the 0.56884765625
▁inter 6.34375
dep 3.650390625
end 0.0006756782531738281
ence 0.01132965087890625
▁of 0.58251953125
▁various 3.90234375
▁factors 1.6240234375
▁that 2.79296875
▁affected 4.15234375
▁the 0.57470703125
▁physical 6.890625
▁and 0.96435546875
▁emot 0.4794921875
ional 0.0003695487976074219
▁condition 1.0107421875
▁of 0.1092529296875
▁patients 0.59814453125
▁e 10.921875
▁x 9.171875
per 1.0166015625
ien 0.0163116455078125
cing 0.004322052001953125
▁chron 0.6259765625
ic 0.0008168220520019531
▁pain 0.0352783203125
. 0.271484375
▁For 3.9375
▁example 1.2373046875
, 0.01812744140625
▁the 1.2265625
▁survey 5.15234375
▁showed 3.458984375
▁that 0.416748046875
▁the 1.732421875
▁ratio 6.9765625
▁of 0.12115478515625
▁female 4.5234375
▁patients 0.79736328125
▁was 1.83203125
▁remark 9.5390625
ably 0.001094818115234375
▁higher 0.5224609375
▁in 2.705078125
▁the 0.99853515625
▁op 4.57421875
i 4.03515625
ates 0.1441650390625
▁group 0.267578125
▁compared 2.732421875
▁to 0.1253662109375
▁the 0.515625
▁MM 0.49462890625
▁group 0.276123046875
. 0.46630859375
▁In 2.982421875
▁turn 4.05078125
, 0.00371551513671875
▁people 5.9609375
▁on 5.4296875
▁op 1.39453125
i 0.444580078125
ates 0.004901885986328125
▁were 1.064453125
▁more 1.005859375
▁likely 0.383056640625
▁to 0.06256103515625
▁report 3.130859375
▁major 5.9765625
▁de 0.3935546875
press 1.2392578125
ive 0.0046539306640625
▁dis 0.490478515625
orders 1.4423828125
. 1.783203125
<0x0A> 2.408203125
The 1.1123046875
▁question 5.65625
na 1.228515625
ires 0.00026988983154296875
▁used 2.005859375
▁different 8.3046875
▁variable 8.671875
▁measures 0.7685546875
▁to 1.373046875
▁collect 2.3515625
▁information 1.94140625
. 1.642578125
▁For 1.998046875
▁example 0.205810546875
, 0.00812530517578125
▁it 4.03515625
▁included 2.478515625
▁compreh 8.640625
ensive 0.0284576416015625
▁so 6.8984375
cio 0.0294342041015625
- 0.416259765625
dem 0.0869140625
ographic 0.037841796875
▁data 1.025390625
: 4.87890625
▁gender 1.611328125
, 0.0908203125
▁age 0.2060546875
, 0.088623046875
▁country 4.34375
, 1.521484375
▁type 4.33984375
▁of 0.050628662109375
▁residence 3.83203125
▁( 3.44140625
urban 2.01953125
/ 2.92578125
r 0.06170654296875
ural 0.0006618499755859375
), 0.230712890625
▁years 5.9453125
▁of 0.170166015625
▁education 0.66796875
, 0.147216796875
▁and 1.841796875
▁employ 3.634765625
ment 0.00445556640625
▁status 0.4560546875
. 0.1734619140625
▁Pat 4.07421875
ients 0.095458984375
▁were 1.1708984375
▁also 0.9111328125
▁asked 0.61376953125
▁about 1.146484375
▁their 0.6162109375
▁medical 2.736328125
▁history 0.39453125
▁over 8.7734375
▁the 0.1611328125
▁years 3.96484375
▁and 1.818359375
▁the 1.833984375
▁current 3.40234375
▁presence 5.76171875
▁of 0.052520751953125
▁any 2.654296875
▁severe 4.59375
▁dise 1.4638671875
ases 0.0001575946807861328
▁such 4.14453125
▁as 0.00559234619140625
▁heart 2.388671875
▁failure 2.033203125
, 0.1829833984375
▁di 1.8447265625
ab 0.0020885467529296875
etes 0.004528045654296875
, 0.133056640625
▁ar 3.76953125
th 0.1376953125
rit 0.03363037109375
is 0.01206207275390625
, 0.04193115234375
▁and 1.56640625
▁so 0.78076171875
▁on 0.030609130859375
. 0.049713134765625
▁The 1.8671875
▁third 7.19921875
▁measure 3.95703125
▁of 2.05859375
▁the 0.9912109375
▁question 2.908203125
naire 0.180419921875
▁was 0.9697265625
▁indicated 9.7265625
▁by 0.60986328125
▁information 6.5390625
▁on 1.5517578125
▁any 5.3203125
▁twelve 13.6015625
- 1.1708984375
month 0.36474609375
▁and 5.8125
▁lifetime 3.19921875
▁drug 4.7109375
▁and 3.498046875
▁alco 0.08087158203125
hol 0.0001093149185180664
▁consumption 2.55078125
. 0.459228515625
▁In 3.474609375
▁addition 0.7841796875
, 0.125244140625
▁the 1.1455078125
▁record 7.890625
▁included 1.7744140625
▁a 2.486328125
▁pain 6.45703125
▁measurement 4.33203125
▁scale 1.0439453125
▁from 3.673828125
▁ 0.46240234375
0 0.447509765625
▁to 0.411376953125
▁ 0.007068634033203125
1 0.09490966796875
0 0.077880859375
▁to 4.62109375
▁evaluate 1.5146484375
▁dis 5.97265625
com 0.2010498046875
fort 0.0016021728515625
▁feelings 7.3671875
▁during 3.32421875
▁the 0.91552734375
▁last 1.408203125
▁month 1.5849609375
. 0.28125
<0x0A> 1.1279296875
Am 6.921875
ong 0.0121612548828125
▁all 2.359375
▁participants 1.9482421875
▁in 3.57421875
▁the 0.17919921875
▁study 0.37744140625
, 0.0574951171875
▁ 0.6630859375
4 1.7470703125
2 2.748046875
. 1.8154296875
2 2.29296875
% 0.1485595703125
▁suffered 4.98046875
▁from 0.1358642578125
▁de 1.814453125
pression 0.1556396484375
, 1.0634765625
▁and 1.765625
▁ 0.1468505859375
3 1.71484375
7 2.232421875
% 2.744140625
▁experienced 2.345703125
▁excess 7.80078125
ive 0.08587646484375
▁anx 0.26416015625
iety 0.0019435882568359375
. 0.341064453125
▁The 1.41015625
▁pl 11.1953125
ur 1.0263671875
ality 0.00023031234741210938
▁of 0.193115234375
▁de 3.572265625
press 1.2900390625
ive 0.0255126953125
▁dis 1.7822265625
orders 0.060211181640625
▁among 3.86328125
▁patients 1.1787109375
▁in 3.6171875
▁the 0.362548828125
▁op 1.4677734375
i 0.97412109375
ates 0.0059814453125
, 7.15234375
▁medical 2.91796875
▁mar 0.020233154296875
iju 0.00738525390625
ana 7.081031799316406e-05
, 0.11383056640625
▁and 0.0626220703125
▁mixed 6.1015625
▁OP 8.84375
MM 5.89453125
▁groups 0.448974609375
▁number 7.98046875
ed 0.01004791259765625
▁ 0.12030029296875
5 2.181640625
7 2.484375
. 0.208251953125
1 2.3671875
%, 0.2430419921875
▁ 0.004642486572265625
2 3.015625
2 2.4375
. 0.10528564453125
3 2.228515625
%, 0.117431640625
▁and 0.032012939453125
▁ 0.003047943115234375
5 3.224609375
1 2.55859375
. 0.167236328125
4 2.146484375
%, 0.38623046875
▁respectively 0.01064300537109375
. 0.271240234375
▁The 1.458984375
▁pl 4.6328125
ur 0.021820068359375
ality 3.802776336669922e-05
▁of 0.040252685546875
▁anx 0.9013671875
iety 0.01239013671875
▁contained 11.0546875
▁ 0.56982421875
4 1.5703125
8 2.380859375
. 0.064697265625
4 2.306640625
% 0.51611328125
▁among 1.44921875
▁OP 6.42578125
▁patients 9.0234375
, 0.27099609375
▁ 0.09832763671875
2 1.501953125
1 2.4140625
. 0.1314697265625
5 2.427734375
% 0.0116729736328125
▁among 0.42333984375
▁MM 0.35888671875
▁patients 0.2457275390625
, 0.01259613037109375
▁and 0.01345062255859375
▁ 0.03741455078125
3 1.23046875
8 2.640625
. 0.1605224609375
7 2.287109375
% 0.01349639892578125
▁among 0.2354736328125
▁OP 4.05078125
MM 0.2197265625
▁participants 3.58203125
. 0.225830078125
▁Pat 5.796875
ients 0.0215301513671875
▁who 2.3671875
▁took 2.890625
▁strong 8.1328125
▁op 1.24609375
i 1.3955078125
ates 0.00415802001953125
▁were 1.7529296875
▁t 8.859375
ended 0.9169921875
▁to 0.0133209228515625
▁place 10.34375
▁their 3.6875
▁pain 2.609375
▁on 3.4765625
▁a 0.87353515625
▁scale 2.30859375
▁of 0.62451171875
▁ 0.3583984375
9 2.806640625
▁to 1.34765625
▁ 0.01543426513671875
1 0.02349853515625
0 0.09246826171875
▁( 2.55859375
Fe 1.6904296875
ing 0.0087432861328125
old 0.0006480216979980469
▁et 0.03033447265625
▁al 0.0010976791381835938
., 0.00708770751953125
▁ 0.0018215179443359375
2 0.0005574226379394531
0 3.993511199951172e-05
1 0.0020084381103515625
7 0.0138397216796875
). 0.0516357421875
▁They 4.69921875
▁were 1.294921875
▁also 1.4052734375
▁an 8.8515625
gu 4.4453125
ished 0.0301666259765625
▁em 8.4140625
otion 0.01035308837890625
ally 0.0032558441162109375
▁and 1.1298828125
▁react 6.859375
ed 0.05596923828125
▁rad 9.515625
ically 0.0037364959716796875
▁neg 5.3828125
atively 0.0009860992431640625
▁to 0.346435546875
▁almost 5.23046875
▁all 1.2041015625
▁survey 8.421875
▁questions 0.6201171875
. 0.292724609375
▁Pat 4.24609375
ients 0.0076904296875
▁who 1.1572265625
▁took 1.49609375
▁only 5.49609375
▁MM 0.8916015625
▁or 3.220703125
▁mixed 3.419921875
▁medic 2.6015625
ations 0.332763671875
▁course 12.6328125
▁had 2.48828125
▁a 1.2744140625
▁significantly 2.5625
▁more 4.078125
▁stable 3.4296875
▁emot 1.20703125
ional 0.007213592529296875
▁state 0.8173828125
▁and 1.423828125
▁cop 5.51171875
ed 0.87158203125
▁with 0.72412109375
▁pain 1.44921875
▁more 1.68359375
▁manage 6.9453125
able 2.39453125
. 0.5185546875
<0x0A> 0.70458984375
One 5.1640625
▁of 0.60400390625
▁the 0.01763916015625
▁major 2.546875
▁limitations 2.771484375
▁is 3.861328125
▁the 0.52197265625
▁ins 4.77734375
u 0.0197906494140625
fficient 0.12359619140625
ly 4.63671875
▁high 2.9609375
▁response 2.994140625
▁rate 0.12139892578125
, 2.62890625
▁ 4.6171875
5 1.9326171875
7 2.068359375
% 2.09375
▁instead 7.34375
▁of 0.006092071533203125
▁ 0.712890625
7 1.5126953125
0 1.455078125
% 1.109375
▁( 1.626953125
Fe 0.2763671875
ing 0.004245758056640625
old 0.0006575584411621094
▁et 0.006626129150390625
▁al 0.000782012939453125
., 0.00484466552734375
▁ 0.0014820098876953125
2 0.0004227161407470703
0 2.6345252990722656e-05
1 0.000942230224609375
7 0.006664276123046875
). 0.03900146484375
▁It 2.66015625
▁can 3.291015625
▁be 0.410400390625
▁fairly 8.359375
▁explained 1.501953125
▁by 0.1712646484375
▁the 0.326171875
▁weak 8.234375
▁focus 7.1171875
▁of 0.459716796875
▁respond 6.28515625
ents 0.135009765625
▁who 3.501953125
▁have 4.015625
▁overcome 8.0546875
▁severe 2.26171875
▁pain 0.5048828125
▁sens 8.703125
ations 1.1259765625
▁and 1.1875
▁de 4.2109375
press 1.7607421875
ive 0.2548828125
▁episodes 3.94921875
. 0.5986328125
▁It 3.33984375
▁is 0.82568359375
▁not 2.6484375
▁clear 4.26171875
▁how 1.6884765625
▁to 3.55859375
▁use 5.390625
▁these 3.02734375
▁statistics 3.376953125
, 2.548828125
▁as 1.4150390625
▁they 1.359375
▁still 6.1015625
▁may 4.7890625
▁be 1.3310546875
▁relevant 5.26953125
▁for 1.396484375
▁the 1.8466796875
▁overall 4.4921875
▁analysis 3.048828125
. 1.0556640625
